Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction.
Saved in:
| Title: | Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction. |
|---|---|
| Authors: | Yisraeli Salman M; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel., Terry AR; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Derkach A; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Nemirovsky D; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Chin KK; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Valtis YK; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Boussi L; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Spivey T; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Xiao W; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Famulare C; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Ciervo J; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Rowe JM; Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel.; Department of Hematology and BMT, Rambam Health Care Campus and Technion, Israel Institute of Technology, Haifa, Israel., Tallman MS; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY., Stein EM; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY. |
| Source: | Blood advances [Blood Adv] 2025 Jul 08; Vol. 9 (13), pp. 3213-3222. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
